Completed NA INTERVENTIONAL 2-arm NCT05827172

AF Ablation for HF With Reduced EF

Catheter Ablation vs. Medical Treatment in Patients With HFrEF and Persistent AF (CAEFR-AF)

Sponsor: Shandong University of Traditional Chinese Medicine

Conditions Heart Failure With Reduced Ejection Fraction Persistent Atrial Fibrillation

Interventions AF ablation medical therapy

Updated 5 times since 2023 Last updated: Apr 12, 2023 Started: Jun 1, 2020 Primary completion: Dec 31, 2021 Completion: Jan 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05827172, this NA trial focuses on Heart Failure With Reduced Ejection Fraction and Persistent Atrial Fibrillation and remains completed. Sponsored by Shandong University of Traditional Chinese Medicine, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Completed NA
Mar 2025 — Jun 2025 [monthly]

Completed NA
Sep 2024 — Mar 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shandong University of Traditional Chinese Medicine
Shanghai Chest Hospital
Tongji University
Yuhuan Second People's Hospital

Data source: Shanghai Chest Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China